scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.RES.14.6.516 |
P698 | PubMed publication ID | 14169970 |
P2093 | author name string | G K MOE | |
J HAN | |||
P GARCIADEJALON | |||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 516-524 | |
P577 | publication date | 1964-06-01 | |
P1433 | published in | Circulation Research | Q2599020 |
P1476 | title | ADRENERGIC EFFECTS ON VENTRICULAR VULNERABILITY | |
P478 | volume | 14 |
Q69412556 | A new method to measure non-uniformity in the intact heart |
Q72103385 | Adrenergic innervation of the heart of the bat, Miniopterus schreibersii |
Q28318683 | Adrenergically Mediated Ventricular Fibrillation in Probucol-Treated Dogs: Roles of Alpha and Beta Adrenergic Receptors |
Q52753161 | Analysis of the mechanism of adrenergic actions on ventricular vulnerability |
Q35118228 | Anger and ventricular arrhythmias |
Q43602423 | Angerlike behavioral state potentiates myocardial ischemia-induced T-wave alternans in canines |
Q72014825 | Antiarrhythmic properties of tris (hydroxymethyl aminomethane) |
Q70039679 | Antifibrillatory effect of beta-adrenergic agonists |
Q41120704 | Antitachycardia pacing: which patients and which methods? |
Q84796994 | Autonomic boundary conditions for ventricular fibrillation and their implications for a novel defibrillation technique |
Q68765890 | Autonomic disturbance at onset of acute myocardial infarction |
Q69558718 | Autonomic disturbance at the onset of acute myocardial infarction |
Q57166822 | Autonomic function and ventricular tachyarrhythmias during acute myocardial infarction |
Q77700059 | Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring Trial |
Q36172467 | Behavioral influences on cardiac arrhythmias |
Q40089304 | Beta adrenoceptor antagonists after myocardial infarction--where are we now? |
Q28366883 | Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium |
Q41537296 | Beta-adrenergic blockade may prolong life in post-infarction patients in part by increasing vagal cardiac inhibition |
Q39874846 | Beta-adrenergic receptor blocking drugs in cardiac arrhythmias |
Q40094391 | Beta-blocking drugs for arrhythmias, hypertension, and ischemic heart disease |
Q68180823 | Bretylium tosylate and electrically induced cardiac arrhythmias during hypothermia in dogs |
Q89338920 | Cardiac and skeletal muscle effects of electrical weapons : A review of human and animal studies |
Q40004932 | Cardiac dysrhythmias in the conscious dog after surgically induced autonomic imbalance |
Q33824095 | Cardiac pacing for cardiac arrest due to hyperkalemia plus digitalis and quinidine toxicity |
Q40126520 | Cellular electrophysiology of ventricular and other dysrhythmias: Studies on diseased and ischemic heart |
Q67039025 | Changes in ventricular fibrillation threshold during repeated short-term coronary occlusion and release |
Q41490385 | Chest wall stimulator for pacemaker inhibiton. |
Q67289107 | Cholinergic Modulation of Enhanced Vulnerability to Ventricular Fibrillation Evoked by Adrenergic Stimulation in the Isolated Rat Heart |
Q52896581 | Circadian variation of QT interval dispersion: correlation with heart rate variability. |
Q33154637 | Congenital Myocardial Sympathetic Dysinnervation (CMSD)-A Structural Defect of Idiopathic Long QT Syndrome |
Q39923598 | Coronary care. The understanding and treatment of atrial and ventricular dysrhythmias |
Q44391021 | Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release |
Q39269019 | Digitalis drugs and vulnerability to ventricular fibrillation |
Q24795922 | Dispersion of cardiac action potential duration and the initiation of re-entry: a computational study |
Q26741074 | Drug therapy in cardiac arrest: a review of the literature |
Q28316920 | Drug therapy of tachyarrhythmias (author's transl) |
Q28342662 | Dynorphin A (1–13) in the brain suppresses epinephrine-induced ventricular premature complexes and ventricular tachyarrhythmias |
Q40335354 | Dysrhythmogenesis associated with the treatment of acute reversible airway obstruction |
Q66921770 | Editorial: Doubts about lignocaine |
Q72691225 | Effect of alpha-adrenergic receptor stimulation on ventricular electrical properties in the normal canine heart |
Q57226450 | Effect of caffeine on the ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction |
Q93796591 | Effect of changes in potassium and calcium concentrations on diastolic threshold and strength-interval relationships of the human heart |
Q68855510 | Effect of coronary collateral development on ventricular fibrillation threshold |
Q34073997 | Effect of lidocaine hydrochloride on membrane conductance in mammalian cardiac Purkinje fibers |
Q67706700 | Effect of stimulation of somatic nerves on the ventricular fibrillation threshold in dogs |
Q54167329 | Effect of ventricular aberrancy on fibrillation threshold |
Q69628351 | Effects of Severe Systemic Hypoxia on Myocardial Excitation |
Q67706706 | Effects of acute hyperkalemia on cardiac excitability |
Q28323106 | Effects of aminophylline on the threshold for initiating ventricular fibrillation during respiratory failure |
Q35585927 | Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias |
Q72529550 | Effects of cardiac glycosides on spontaneous efferent activity in vagus and sympathetic nerves of cats |
Q69518635 | Effects of collateral circulation on electrophysiological properties during the acute phase of canine myocardial infarction |
Q74530516 | Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome |
Q52736658 | Effects of lignocaine, propranolol and bretylium on ventricular fibrillation threshold |
Q72681861 | Effects of premature depolarization on refractoriness of ischemic canine myocardium |
Q44262035 | Effects of vagal stimulation, atropine, and propranolol on fibrillation threshold of normal and ischemic ventricles |
Q52701658 | Electrophysiological and haemodynamic effects of a new inotropic agent (UK 14275) in the dog |
Q41556235 | Electrophysiological mechanisms of ventricular fibrillation induction. |
Q38136550 | Electrophysiology and pharmacology of cardiac arrhythmias IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part A |
Q42250352 | Facilitation of ventricular tachyarrhythmia induction by isoproterenol |
Q52274072 | Fish oil may be an antidote for the cardiovascular risk of smoking. |
Q72219803 | Hemodynamic and electrocardiographic effects of hyperpotassemia. Differences in response to slow and rapid increases in concentration of plasma K |
Q35696022 | Hindlimb unloading results in increased predisposition to cardiac arrhythmias and alters left ventricular connexin 43 expression |
Q39944673 | Hyperkalemia, cardiac conduction, and the electrocardiogram: A review |
Q34118634 | Impaired vagal heart rate control in coronary artery disease |
Q66852411 | Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study |
Q41675685 | Iodine 123-labeled metaiodobenzylguanidine imaging in heart disease |
Q70971763 | Linear Relationship Between Electrical Systole, Mechanical Systole, and Heart Rate |
Q44471398 | Manifestation of the Wolff-Parkinson-White syndrome after myocardial infarction |
Q37049805 | Mechanisms Contributing to Malignant Dysrhythmias Induced by Ischemia in the Cat |
Q38994776 | Mental Stress and Ventricular Arrhythmias |
Q34375971 | Neural and psychologic mechanisms and the problem of sudden cardiac death |
Q33171049 | Paroxysmal familial ventricular fibrillation |
Q42015288 | Periodic Repolarisation Dynamics: A Natural Probe of the Ventricular Response to Sympathetic Activation |
Q69594587 | Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease |
Q40441752 | Proarrhythmic Effects of Intravenous Vasopressors |
Q74605497 | Prognosis in myocardial infarction survivors with left ventricular dysfunction is predicted by electrocardiographic RR interval but not QT dispersion |
Q41404372 | Propranolol blocks ventricular refractory period changes with orthostatic stress in humans |
Q35901395 | Psychological aspects of cardiac arrhythmia |
Q54782655 | Psychological stress and ventricular arrhythmias during myocardial infarction in the conscious dog |
Q41386939 | Psychosocial aspects of surviving sudden cardiac death |
Q33171209 | Q-T Prolongation and ventricular arrhythmias, with and without deafness, in the same family |
Q58011832 | ROLE OF CATECHOLAMINES IN ARRHYTHMIAS AFTER ACUTE MYOCARDIAL INFARCTION |
Q71756598 | Repetitive ventricular fibrillation in myocardial infarction refractory to bretylium tosylate subsequently controlled by ventricular pacing |
Q45083292 | Sensitization by low temperature of the isolated perfused heart to induced ventricular fibrillation |
Q54378704 | Sensitization to an induced persistent ventricular fibrillation or tachycardia by quinidine in the isolated perfused rabbit heart. |
Q42979402 | Sequence of epicardial repolarisation and configuration of the T wave |
Q36245851 | Simple finite-element model accounts for wide range of cardiac dysrhythmias |
Q45300661 | Spectrum of sinus node dysfunction in two siblings |
Q72650246 | Stellatum blockade and long-QT syndrome (author's transl) |
Q34569207 | Stimulus-induced critical point. Mechanism for electrical initiation of reentry in normal canine myocardium |
Q37679996 | Sympathetic activity-associated periodic repolarization dynamics predict mortality following myocardial infarction |
Q35171874 | Sympathetic nervous system activity and ventricular tachyarrhythmias: recent advances. |
Q66951428 | Sympatho-adrenal activity in acute cold stress. The mechanism of sudden death following water immersion |
Q70134487 | Systolic and diastolic pacemaker induced repetitive firing in the human heart. Analysis of 23 cases |
Q71748017 | T-wave abnormalities during hyperventilation and isoproterenol infusion |
Q69973096 | Temporal dispersion of recovery of excitability in atrium and ventricle as a function of heart rate |
Q33171073 | The Q-T Syndrome-A Family Description |
Q71574853 | The action of ouabain on the chronotropic effects of sympathetic nerve stimulation and isoproterenol |
Q40006219 | The effect of anoxia on the ventricular fibrillation threshold in the rabbit isolated heart |
Q39996882 | The effect of sympathomimetic amines on the ventricular fibrillation threshold in the rabbit isolated heart |
Q39465789 | The medical treatment of angina pectoris |
Q46534374 | The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation |
Q37161633 | The role of the autonomic nervous system in sudden cardiac death. |
Q64943559 | The sequence of normal ventricular recovery |
Q68305820 | The use of epinephrine in the treatment of older adult asthmatics |
Q68996865 | Using body surface mapping to detect vulnerability to ventricular arrhythmias in patients with coronary artery disease |
Q53973258 | Ventricular conduction delay and asystole during systemic hyperkalemia |
Q45007911 | Ventricular electrical instability in the conscious dog: effects of psychologic stress and beta adrenergic blockade |
Q39920772 | Ventricular fibrillation precipitated by carotid sinus pressure: Case report and review of the literature |
Q41456667 | Ventricular fibrillation threshold for AC shocks of long duration, in dogs with normal acid-base state |
Q44900427 | Vulnerability of Canine Ventricle to Fibrillation During Hypoxia and Respiratory Acidosis |
Q67347249 | Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and release |
Q38277446 | β-Adrenergic modulation of myocardial conduction velocity: Connexins vs. sodium current. |
Search more.